Tenofovir alafenamide (TAF)

Published February 2016; Updated October 2017
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-01-09
Selected Reference
4. Mills A, Andrade-Billanueva J, DiPerri G, et al. Switching from a tenofovir disoproxil fumarate (TDF)-based regimen to a tenofovir alafenamide (TAF)-based regimen: data in virologically suppressed adults through 48 weeks of treatment. In: Program and abstracts of the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2015; Vancouver, BC, Canada. Abstract TUAB0102.